Actualités de BRUSSELS

Filtre
  • 27.07.2020 – 07:10

    UCB Pharma

    UCB Half Year Report 2020

    Brussels (ots/PRNewswire) - - UCB's resilient product portfolio drives continued company growth - Revenue increased to EUR 2.6 billion and net sales to EUR 2.5 billion, both +12%, +9% CER or +10% at CER and adjusted for divestitures respectively - Underlying profitability (adj. EBITDA) was EUR 783 million (+8%, 0% CER) or a ratio of 30% - Ra Pharma acquisition closed early April, Engage Therapeutics acquired in June, co-promotion agreement for Cimzia® with Ferring in July - ...

  • 18.06.2020 – 19:11

    Euroclear Holding, Euroclear Investments, Euroclear SA/NV

    Euroclear: Directorate Changes

    Brussels (ots/PRNewswire) - The Euroclear group announces that Marc Antoine Autheman has decided to step down as the Chairman and Director of the Euroclear boards. During Mr Autheman's eight year tenure, Euroclear's strategy has resulted in its strong financial position and performance, delivering consistently growing returns for shareholders and value for its financial market participants, whilst adapting to meet the requirements of the post-financial crisis regulatory and ...

  • 12.05.2020 – 14:48

    Anywhere365

    Anywhere365, the Leading Microsoft Teams Focused Cloud Contact Center Provider, Receives a Follow-on Investment of EUR20 Million From Existing Investor Bregal Milestone

    Rotterdam, Netherlands, London, Atlanta and Brussels (ots/PRNewswire) - Appoints Senior Microsoft Executive Will Blench to the Board of Directors and Hires Nasdaq-Experienced Finance Director Frans Koch as CFO to Accelerate Global Expansion Anywhere365, the leading software provider for Enterprise Dialogue ...

  • 17.04.2020 – 10:05

    Euroclear Holding

    Euroclear Business and Financial Update - Q1 2020

    Brussels (ots/PRNewswire) - - Business Income rose 15% to EUR 321 million - Banking and Other Income decreased 14% to EUR 62 million - Q1 20 revenues up 9% year-on-year, to EUR 383 million - Operating costs up by 4% to EUR 213 million, in line with expectations - Net profit was up 29% to EUR 127 million - Dividend approval to be postponed to Q4 2020 in light of recent ECB guidance - Liquidity initiative stopped due to ...

  • 10.04.2020 – 15:00

    UCB Pharma

    UCB's General Meeting of Shareholders

    Brussels (ots/PRNewswire) - - Update on attendance and voting instructions relating to UCB's General Meeting of 30 April 2020 - Implementation of Royal Decree n°4 of 9 April 2020 on various provisions regarding the legislation on co-ownership and companies and associations, in the framework of the fight against the Covid-19 pandemic - No physical presence at General Meeting allowed and votes can only be submitted by ...